Article: Nicotinamide Riboside Supplementation in Mild Cognitive Impairment: Clinical Findings

Nov 23, 2023 Clinical Mild Cognitive Impairment Neurological Health

Nicotinamide Riboside Supplementation in Mild Cognitive Impairment: Clinical Findings

Objectives

To determine the safety of oral NR supplementation in older adults with mild cognitive impairment (MCI), and investigate its effects on cognition, brain volume and functioning, and physical function.

Journal

GeroScience

Key Outcomes

Cognitive function measures remained stable in both NR and placebo groups throughout the study.
Global methylation analyses trended towards a modest NR-associated increase in DNA methylation.

Duration

10 weeks

Dose

1000 mg

Study Design

Randomized, double-blind, placebo-controlled, phase II, pilot study in 20 primarily Hispanic older adults with mild cognitive impairment (MCI)

See Published Study

Immune Health

Role of nadR Gene in Growth and Virulence of Streptococcus suis Bacteria: Preclinical Findings

SynopsisStreptococcus suis serotype 2 (SS2) is a harmful bacterium in pigs that can also infect humans. This study investigated the role of the nadR gene, which helps make and transport NAD+ inside...

Cardiovascular Disease

Nicotinamide Riboside Improves Mitochondrial Function and Survival Post-Heart Attack: Preclinical Findings

SynopsisMyocardial infarction (MI), or heart attack, is a leading cause of death, and reduced NAD+ levels in the heart can worsen damage after MI. This study tested whether nicotinamide riboside (N...